Blog

  1. Troc-OSu

    Reported applications:

    Introduction of 9-fluorenylmethyloxycarbonyl, trichloroethoxycarbonyl, and benzyloxycarbonyl amine protecting groups into O-unprotected hydroxylamino acids using succinimidyl carbonates; Anelka Paquet; Can. J. Chem.; 1982; 60: 976.

    Widely Applicable Deprotection Method of 2,2,2-Trichloroethoxycarbonyl (Troc) Group Using Tetrabutylammonium Fluoride; Cheng-yuan Huanga; Ning Wanga; Katsumasa Fujikia; Yuji Otsukaa; Masao Akamatsua; Yukari Fujimotoa; Koichi Fukasea; Journal of Carbohydrate Chemistry 2010; 29(6): 289 – 298.

    Read more
  2. DTT (Cleland's Reagent)

    Cleland's reagent, also known as dithiothreitol or DTT is a water soluble protective reagent for sulfhydryl groups.
    It reduces disulfide linkages to free sulfhydryl groups in proteins and enzymes.
    It is a component of buffers used in protocols for the isolation and purification of proteins.

    DTT (racemic), Cleland's Reagent

    Read more
  3. Actiplus-CALB

    Lipase B from Candida antarctica (EC 3.1.1.3)
    adsorbed on hydrophobic polymer Polystyrene DVB cross linked, 300-700µm,
    Synthetic Activity >10.000 U/g (dry), 
    very high mechanical stability - suitable for packed bed reactors

    Read more
  4. Green Advantages of using Phacm for Cystein Protection

    PGA (Penicillin G Amidase, Penicillin Acylase, Penicillin Amidohydrolase from E.coli on acrylic resin, Systematic name: Penicillin amidohydrolase, E.C. 3.5.1.11) has an active pocket, which is very specific for phenyl acetic acid. The prominent commercial use is hydrolysis of a phenylacetamid bond during production of the penicillin API 6-APA (De Martin et al., J. Mol. Catal. B:Enzymatic 1999; 6: 437). The high specifity of PGA towards the Phenylacetyl moiety makes the use of Phacm as new alternative for Acm very promising. The principle use already was discovered by Albericio et al in 1995 using native PGA. Today PGA is available as immobilized preparation, so by simple filtration process PGA can be removed from the reaction mixture and reused many times.

    Read more
  5. Dendron Building Blocks for Click Chemistry

    Dendrimers offer a new possibility to derivatize small molecules, surfaces or biopharmaceuticals with a monodisperse macromolecule and alter in this way properties like solubility and hydrophilicity. Immunogenicity and pharmacokinetics of pharmaceuticals will be improved. The synthetic approach for designing these dendrons of different generations is based on 2,2-bis(hydroxymethyl) propionic acid, which is a non-toxic and biocompatible building block.

    The size can be designed from 250 g/mole for 1st generation dendrons to over 4400 g/mole with 5th generation compounds. Dendrimers can be designed reaching even a molecular weight of some 10.000 Da. As focal point alkyne and azido functions are used with appropriate counter parts in any type of click chemistry reaction. Olefinic functions offer the possibility for addition reaction or conjugation by metathesis reactions or photo reactions with the aid of UV light. For the modification of Gold surfaces sulphur bearing dendrons can be used, they also conjugate with biologicals via disulfide bridge formation.

    Read more
  6. Parallel Synthesis and Reaction Optimization

    Read more
  7. Understanding enzyme immobilisation

    Read more
  8. The concept of internal solubilization in peptide synthesis: ethylene glycol-based protecting groups

    A novel, ethylene glycol-based protecting group is designed and synthesized for use in solid phase peptide synthesis.

    Read more
  9. Shorter Arginine homologues to stabilize peptides towards tryptic digestion

    Abstract: Trypsin digests peptides at the position of arginine. Because shorter homologues of arginine with appropriate protecting groups for conventional Fmoc/tBu peptide synthesis are now available, three model peptides containing arginine and two shorter homologues of arginine were synthesized.

    Read more
  10. PEGylation - The Magic Wand IRIS Biotech GmbH - Turning Proteins and other Biopharmaceuticals into Super Performing Block Busters

    Abstract: In 2006 the market of modern biopharmaceuticals has reached a volume of over 3 billion in USA and over billion world wide (IMS Health, Inc.).

    Read more
  11. Items 631-640 of 645
    Show per page